» Articles » PMID: 31175383

Superconditioning TMS for Examining Upper Motor Neuron Function in MND

Overview
Journal Exp Brain Res
Specialty Neurology
Date 2019 Jun 9
PMID 31175383
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We used transcranial magnetic stimulation (TMS) of motor cortex, including a novel four-pulse superconditioning (TMSsc) paradigm, in repeated examinations of motor-evoked potentials (MEPs) in eight subjects with motor neuron disease (MND), including seven with amyotrophic lateral sclerosis (ALS). The goals were: (1) to look for evidence of cortical hyperexcitability, including a reduction in short-interval intracortical inhibition (SICI); and (2) to examine the utility of using TMSsc for quantifying upper motor neuron function during MND progression. Testing of abductor pollicis brevis (APB) and tibialis anterior (TA) muscles bilaterally was carried out every 3 months in MND subjects for up to 2 years; results were compared to those from a cohort of 15 control subjects. Measures of SICI were not significantly different between control and MND subjects for either APB or TA muscles. Other measures of cortical excitability, including TMS threshold and MEP amplitude, were consistent with lowered cortical excitability in MND subjects. Certain combinations of superconditioning TMS were capable of causing stronger inhibition or facilitation of MEPs compared to dual-pulse TMS, for both APB and TA target muscles. Moreover, there were multiple cases in which target muscles unresponsive to strong single-pulse TMS, whether at rest or when tested with an active contraction, showed an MEP in response to TMSsc optimized for facilitation. Our findings suggest that a multi-faceted neurophysiologic protocol for examining upper motor neuron function in MND subjects might benefit from inclusion of TMSsc testing.

Citing Articles

Revisiting motor unit recruitment to TMS in amyotrophic lateral sclerosis: cortical inhibition is retained during voluntary contractions.

Calancie B, Alexeeva N Exp Brain Res. 2025; 243(2):51.

PMID: 39843865 DOI: 10.1007/s00221-024-06961-1.


Motor potentials evoked by transcranial magnetic stimulation: interpreting a simple measure of a complex system.

Spampinato D, Ibanez J, Rocchi L, Rothwell J J Physiol. 2023; 601(14):2827-2851.

PMID: 37254441 PMC: 10952180. DOI: 10.1113/JP281885.


On the Use of TMS to Investigate the Pathophysiology of Neurodegenerative Diseases.

Rawji V, Latorre A, Sharma N, Rothwell J, Rocchi L Front Neurol. 2020; 11:584664.

PMID: 33224098 PMC: 7669623. DOI: 10.3389/fneur.2020.584664.

References
1.
Triggs W, Menkes D, Onorato J, Yan R, Young M, Newell K . Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology. 1999; 53(3):605-11. DOI: 10.1212/wnl.53.3.605. View

2.
Awiszus F, Feistner H, Urbach D, Bostock H . Characterisation of paired-pulse transcranial magnetic stimulation conditions yielding intracortical inhibition or I-wave facilitation using a threshold-hunting paradigm. Exp Brain Res. 1999; 129(2):317-24. DOI: 10.1007/s002210050901. View

3.
Caramia M, Palmieri M, Desiato M, Iani C, Scalise A, Telera S . Pharmacologic reversal of cortical hyperexcitability in patients with ALS. Neurology. 2000; 54(1):58-64. DOI: 10.1212/wnl.54.1.58. View

4.
Sasaki S, Iwata M . Immunocytochemical and ultrastructural study of the motor cortex in patients with lower motor neuron disease. Neurosci Lett. 2000; 281(1):45-8. DOI: 10.1016/s0304-3940(00)00789-8. View

5.
Stefan K, Kunesch E, Benecke R, Classen J . Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol. 2001; 49(4):536-9. View